Laboratory study demonstrates that cap-loaded benzonase degrades post-amplification DNA in closed tubes, suggesting an effective contamination control strategy for point-of-care diagnostics.
Ineffective contamination prevention strategies significantly limit the deployment of nucleic acid testing in point-of-care (POC) settings. We herein propose a benzonase-based closed-tube strategy that degrades amplification products of nucleic acid. During the amplification reaction in the tube, Benzonase is kept on the inner surface of the tube cap. The subsequent shaking allows efficient degradation of the amplification products. Experimental results demonstrate that Benzonase remains active after high-temperature treatment, which does not interfere with real-time signal detection. We have further evaluated its ability to reduce carry-over contamination, and a significant decrease in contamination events can be observed. Moreover, this strategy is compatible with POC techniques, such as colorimetric and electrochemical assays. It could be integrated with various nucleic acid amplification strategies and offers the potential to support a wider range of signal output formats.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: